Stock Market News

6 days NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance

NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley.

Morgan Stanley (MS) · Pfizer (PFE)

2 days Northern Trust price target lowered to $125 from $127 at Morgan Stanley Yahoo Finance

2 days State Street price target lowered to $132 from $139 at Morgan Stanley Yahoo Finance

2 days BNY Mellon price target lowered to $90 from $94 at Morgan Stanley Yahoo Finance

2 days Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune

2 days Morgan Stanley’s Mike Wilson: Investors are getting a good return on cash these days YouTube

3 days Infosys to outperform on deal wins, growth outlook, Morgan Stanley says Investing.com

3 days Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks

3 days Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks

3 days Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha

3 days The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

3 days The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks

3 days Xiaomi: Morgan Stanley sees stronger EV shipments in 2025 Investing.com

3 days Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks

3 days Morgan Stanley mulls adding crypto to E-Trade: Report Cointelegraph

3 days Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks

4 days Cybersecurity Firms Cloudflare, CyberArk Advance Amid Chinese Hacks Investor's Business Daily

4 days Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks

4 days Morgan Stanley to leave sector climate coalition Investing.com

4 days Morgan Stanley to leave sector climate coalition Yahoo Finance

4 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

4 days Can Morgan Stanley (MS) Keep the Earnings Surprise Streak Alive? Zacks

5 days Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha

5 days Morgan Stanley (MS) Stock Moves -0.02%: What You Should Know Zacks

5 days Morgan Stanley Direct Lending: Growing And Diversifying Its Portfolio Seeking Alpha

5 days 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

6 days Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch

6 days Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance

6 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

6 days Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance

6 days Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance

6 days Morgan Stanley (MS) is Attracting Investor Attention: Here is What You Should Know Zacks

6 days Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance

6 days 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance

6 days Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com

6 days SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks

6 days Morgan Stanley (MS) Stock Moves -0.8%: What You Should Know Zacks

6 days Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com

6 days Pfizer: One Of The Next Big AI Winners Seeking Alpha

7 days Morgan Stanley comments as Turkey investigates steel imports from China and South Korea Investing.com

1 week Morgan Stanley boosts consumer finance outlook for 2025 Investing.com

1 week New Mexico DPP program approval positive for Ardent Health, says Morgan Stanley Yahoo Finance

1 week Morgan Stanley Sees Potential Growth in These 2 Surgical Robotic Stocks Yahoo Finance

1 week Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks

1 week Why Morgan Stanley’s Jim Lacamp says investors should ‘be really careful’ in 2025 YouTube

2 weeks Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

2 weeks Pfizer: Why I’m Staying On The Sidelines Seeking Alpha

2 weeks Better Income Stock: Pfizer or Altria Group? Yahoo Finance

2 weeks Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

2 weeks Morgan Stanley Series A: True Perpetual Preferred Shares, 5.9% Yield Seeking Alpha

2 weeks Expect heightened volatility in first half of 2025, says Morgan Stanley Private Wealth’s Simonetti YouTube